Pharma Reviews: Pharma sector to create 58000 more jobs by 2025, feel experts

In spite of prevailing challenges in the Indian pharma sector, 58,000 additional job opportunities are likely to be created as the industry is expected to ...
Read more: Pharma sector to create 58000 more jobs by 2025, feel experts

Pharma Reviews: Despite Challenges Pharma Sector to Grow and Generate High Employment - Experts

The Pharmaceutical segment is an integral part of the Indian healthcare market, a market worth approximately Rs. 100 billion, growing with a CAGR of ...
Read more: Despite Challenges Pharma Sector to Grow and Generate High Employment - Experts

Pharma Reviews: NPPA's 'suspicion' of drug overpricing upsets industry

Reacting to the development, D. G. Shah, Secretary General of the Indian Pharmaceutical Alliance, which has leading Indian pharmaceutical ...
Read more: NPPA's 'suspicion' of drug overpricing upsets industry

US FDA News: FDA approves Xermelo for carcinoid syndrome diarrhea

The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.
Read more: FDA approves Xermelo for carcinoid syndrome diarrhea

Pharma Reviews: Need to keep pace with industry on tech upgradation: Sun Pharma

The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi ...
Read more: Need to keep pace with industry on tech upgradation: Sun Pharma

US FDA News: Edex (alprostadil for injection) 10 mcg 2 Pack by Endo Pharmaceuticals: Recall - Potential Lack of Sterility Assurance

Loss of container closure integrity could impact the product’s sterility assurance and may lead to serious adverse events such as infections, both localized at the site of injection and systemically.
Read more: Edex (alprostadil for injection) 10 mcg 2 Pack by Endo Pharmaceuticals: Recall - Potential Lack of Sterility Assurance

Pharma Reviews: Growth in Indian pharma exports revives in the third quarter

Indian pharma companies have received 388 ANDAs during 2015 and 386 ANDAs in 2016 till November. They export almost 50 per cent of the total ...
Read more: Growth in Indian pharma exports revives in the third quarter

Pharma Reviews: Despite challenges pharma sector to grow and generate high employment: Experts

Jaipur, Feb 26 : With the initiatives taken by the Government of India on demonetization, introduction of the GST along with Make in India, Smart Cities, ...
Read more: Despite challenges pharma sector to grow and generate high employment: Experts

Pharma Reviews: See commitment from Indian pharma to address concerns: MHRA

Speaking from the sidelines of the India Pharmaceutical Forum 2017, Heddell said that there are problems in other parts of the world and not just India ...
Read more: See commitment from Indian pharma to address concerns: MHRA

Pharma Reviews: Indian firms getting better in quality of applications, says top drug regulator Caroline Larsen Le ...

In a freewheeling interview to The Indian Express on the sidelines of the Indian Pharmaceutical Forum, Caroline Larsen Le Tarnec, the head of public ...
Read more: Indian firms getting better in quality of applications, says top drug regulator Caroline Larsen Le ...

Pharma Reviews: Pharmaceutical industry showing disinterest in boosting local exports

Goa is considered as export hub by the Indian pharmaceutical industry. Most MNC and domestic companies have their plants in either Verna or ...
Read more: Pharmaceutical industry showing disinterest in boosting local exports

Pharma Reviews: Despite challenges pharma sector to grow and generate high employment: Experts

Jaipur, Feb 26 (IBNS): With the initiatives taken by the Government of India on demonetization, introduction of the GST along with Make in India, Smart ...
Read more: Despite challenges pharma sector to grow and generate high employment: Experts

Pharma Reviews: Another US Warning on Indian Drugs Over Lax Quality

Mumbai: The US Food and Drug Administration (FDA) wants Indian drug manufacturers to get their act together, citing instances of sale of drugs which ...
Read more: Another US Warning on Indian Drugs Over Lax Quality

Pharma Reviews: Govt set to put Rs 1000 cap on pharma companies' gifts for doctors

The Indian pharmaceutical market, pegged at sales of over Rs 1 lakh crore annually, is one of the largest and fastest growing markets worldwide.
Read more: Govt set to put Rs 1000 cap on pharma companies' gifts for doctors

Pharma Reviews: Indian Pharmaceutical Firms Focus On Automation & Work Culture To Improve Quality Standards

A long list of regulatory warnings received by Indian pharmaceutical companies has pushed the sector's top executives to come together and draw ...
Read more: Indian Pharmaceutical Firms Focus On Automation & Work Culture To Improve Quality Standards

Pharma Reviews: Lupin, Sun Pharma report delays in digitising labs

A wave of unfavourable inspections of Indian pharmaceutical plants by the US FDA have put pressure on the industry that supplies 40% of the generic ...
Read more: Lupin, Sun Pharma report delays in digitising labs

Pharma Reviews: Pharma industry needs to adopt more IT tools to upgrade quality standards

Mumbai: Indian pharmaceutical industry needs to enhance the use of ... (IT) tools to upgrade its quality standards, key executives of drug companies ...
Read more: Pharma industry needs to adopt more IT tools to upgrade quality standards

US FDA News: Avella Specialty Pharmacy Unexpired Sterile Injectable Products Labeled “Latex Free”: Recall - Products May Contain Synthetic or Natural Latex

Risk of potential adverse events can range from local site reactions including swelling and inflammation, to allergic reactions which could be life-threatening to users who are sensitive to latex.
Read more: Avella Specialty Pharmacy Unexpired Sterile Injectable Products Labeled “Latex Free”: Recall - Products May Contain Synthetic or Natural Latex

Pharma Reviews: Pharma honchos pitch for 'quality transformation' exercise

Organised by the Indian Pharmaceutical Alliance, the quality conclave saw the participation of regulatory representatives from the United States Food ...
Read more: Pharma honchos pitch for 'quality transformation' exercise

Pharma Reviews: India's Pharma Barons Are Reporting Delays in Digitizing Labs

Meanwhile, a project by Sun Pharmaceutical Industries Ltd., India's largest drug maker, to make all its labs paperless and record all the processes ...
Read more: India's Pharma Barons Are Reporting Delays in Digitizing Labs

Pharma Reviews: US FDA raises concerns on drugs sold in India

US Food and Drug Administration wants Indian drug manufacturers to get their act together citing instances of sale of drugs that lack requisite drug ...
Read more: US FDA raises concerns on drugs sold in India

Pharma Reviews: India engaging more with global regulators to improve drug quality norms

The increasing dialogue between regulators is important as it helps Indian pharma industry to understand the expectations of global inspectors when ...
Read more: India engaging more with global regulators to improve drug quality norms

US FDA News: FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis

The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
Read more: FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis

US FDA News: FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

The U.S. Food and Drug Administration today allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify organisms that cause bloodstream infections and provide information about which antibiotics the organism is likely to respond to (antibiotic sensitivity).
Read more: FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

Pharma Reviews: CII moots pharma industrial estate, naphtha unit in TN

Confederation of Indian Industry (CII) has pitched, among other things to the Tamil Nadu government, for creation of a new pharma industrial estate ...
Read more: CII moots pharma industrial estate, naphtha unit in TN

Pharma Reviews: Despite regulatory issues, pharma regulators positive on outlook

There's no end in sight for the Indian pharmaceutical industry's struggles with domestic and foreign drug regulators. It's true that quite a few companies ...
Read more: Despite regulatory issues, pharma regulators positive on outlook

Pharma Reviews: Pharma body comes up with new guidelines on data integrity

The Indian Pharmaceutical Alliance (IPA), an industry lobby group representing large domestic drug makers, on Thursday released guidelines on data ...
Read more: Pharma body comes up with new guidelines on data integrity

Pharma Reviews: Pharma industry body proposes guidelines on data reliability

The data reliability guidelines were released on Thursday at the second edition of IPA's quality excellence conference, India Pharmaceutical Forum ...
Read more: Pharma industry body proposes guidelines on data reliability

Pharma Reviews: Pharmarack Technologies to go pan India by end-2017

The company aims to create a strong impact across the entire supply chain matrix in the Indian pharmaceutical sector, which is pegged at Rs.1 lakh ...
Read more: Pharmarack Technologies to go pan India by end-2017

Pharma Reviews: Vice President Ansari's visit will pave way for business opportunity: Honorary consul to Uganda

Talking about the cooperation between India and Uganda in pharmaceutical sector, Consul Agrawal, who is also a vice-chairman of Ajanta Pharma ...
Read more: Vice President Ansari's visit will pave way for business opportunity: Honorary consul to Uganda

US FDA News: XtraHRD Natural Male Enhancement Capsules by Organic Herbal Supply, Inc.: Recall - Undeclared Drug Ingredient

Undeclared tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
Read more: XtraHRD Natural Male Enhancement Capsules by Organic Herbal Supply, Inc.: Recall - Undeclared Drug Ingredient

Pharma Reviews: Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO

“There is a lot of pressure that is building on the Indian pharma industry in particular due to the change of the President of USA. He is going to lead a ...
Read more: Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO

US FDA News: Louisiana drug and dietary supplement maker ordered to cease operations due to federal violations

On Friday, U.S. District Judge Robert G. James for the U.S. District Court for the Western District of Louisiana entered a consent decree of permanent injunction against Pick and Pay Inc./Cili Minerals, a manufacturer and distributor of drugs and dietary supplements, and its owner, Anton S. Botha, requiring the business to immediately cease operations until it comes into compliance with federal laws.
Read more: Louisiana drug and dietary supplement maker ordered to cease operations due to federal violations

Pharma Reviews: Systech to participate in seminar series organised by US Consulates in India

The theme of the seminars is 'Risk Mitigation in the Indian Pharmaceutical Industry: The Criticality of Protecting US Exports and Fighting Counterfeits ...
Read more: Systech to participate in seminar series organised by US Consulates in India

Pharma Reviews: Medical tourism to keep pharma industry in good health: study

Mumbai: Indian pharmaceuticals market is expected to touch USD 55 billion in size by 2020 from USD 36.7 billion in 2016, growing at a compound ...
Read more: Medical tourism to keep pharma industry in good health: study

Pharma Reviews: Need no monopoly in healthcare in India: YK Hamied, Chairman, Cipla

ET Now: What are your thoughts on the growth of the Indian pharma sector, what do you think are the key challenges in the face of protectionism and a ...
Read more: Need no monopoly in healthcare in India: YK Hamied, Chairman, Cipla

Pharma Reviews: US Chamber ranks India at bottom in its IP report, Indian Pharmaceutical Alliance terms it flawed ...

Expressing concern over US Chamber of Commerce's Global Intellectual Property Report ranking India at bottom level due to balanced IP system, ...
Read more: US Chamber ranks India at bottom in its IP report, Indian Pharmaceutical Alliance terms it flawed ...

Pharma Reviews: Pharma industry to touch $55 billion in 3 years: study

Indian pharmaceuticals market is expected to touch $55 billion by 2020, from the current level of $36.7 billion in 2016, growing at a compound annual ...
Read more: Pharma industry to touch $55 billion in 3 years: study

Pharma Reviews: Pharma industry to reach $55 billion in three years, says ASSOCHAM-IITTM study

MANGALURU: Indian pharmaceuticals market is expected to touch US $55 billion by 2020 from the current level of US $36.7 billion in 2016 growing at ...
Read more: Pharma industry to reach $55 billion in three years, says ASSOCHAM-IITTM study

Pharma Reviews: Medical tourism to keep pharma industry in good health: Study

Indian pharmaceuticals market is expected to touch USD 55 billion in size by 2020 from USD 36.7 billion in 2016, growing at a compound annual ...
Read more: Medical tourism to keep pharma industry in good health: Study

Pharma Reviews: Pharma industry to reach $55 bn in 3 years: Study

Indian pharmaceuticals market is expected to touch 55 billion dollars by 2020 from the current level of 36.7 billion dollars in 2016 growing at a ...
Read more: Pharma industry to reach $55 bn in 3 years: Study

Pharma Reviews: UN's WHO gives India's vaccine regulatory body NRAI highest ratings

As per an estimate, Indian pharmaceutical companies exported USD 25 billion worth of products in FY 2014-15. • Moreover, India is one of the major ...
Read more: UN's WHO gives India's vaccine regulatory body NRAI highest ratings

Pharma Reviews: Indian pharma companies still wary of US drug market

Cut to 2015, when Indian drug makers' growth hit a speed bump because of manufacturing issues. While a couple of India's biggest pharma firms ...
Read more: Indian pharma companies still wary of US drug market

Pharma Reviews: Pharma stocks up 4% in Jan and Feb despite Donald Trump's proposed policies

Mumbai: Despite concern and scepticism around pharmaceutical stocks, ... What is ailing the sector is worry that US revenue for most Indian pharma ...
Read more: Pharma stocks up 4% in Jan and Feb despite Donald Trump's proposed policies

Pharma Reviews: Will this year's 'Special 301 report' Trump up something?

But pharma industry circles watch it closely for the damage it can do by ... earlier this month by the Indian Pharmaceutical Alliance (IPA) to the USTR.
Read more: Will this year's 'Special 301 report' Trump up something?

Pharma Reviews: Dilip Bhat positive on pharma sector

So, why should Indian pharma companies really trade so high? So, that challenge remain in my opinion not just for the pharma companies but for ...
Read more: Dilip Bhat positive on pharma sector

Pharma Reviews: Supportive policy needed for pharma industry to sustain growth momentum: FICCI president

Indian pharma industry wants a strong and supportive policy framework to continue its growth momentum, said Pankaj Patel, president, Federation of ...
Read more: Supportive policy needed for pharma industry to sustain growth momentum: FICCI president

Pharma Reviews: Domestic pharmaceutical firms seek removal of India from USTR list of weak IPR regimes

The Indian Pharmaceutical Alliance (IPA), which comprises top-notch domestic drug companies, has dispatched a letter to the United States Trade ...
Read more: Domestic pharmaceutical firms seek removal of India from USTR list of weak IPR regimes

US FDA News: Comprehensive Reverse Shoulder by Zimmer Biomet: Class I Recall - High Fracture Rate

Fractures may result in revision surgeries which could cause serious adverse health consequences such as permanent loss of shoulder function, infection, or rarely, death.
Read more: Comprehensive Reverse Shoulder by Zimmer Biomet: Class I Recall - High Fracture Rate

Pharma Reviews: Commerce, Industry depts to simplify investment norms to fast track pharma & medical device ...

This shows that maximum attention is being extended to the sector, said the Minister Sitharaman who was in Bengaluru for the India pharma and ...
Read more: Commerce, Industry depts to simplify investment norms to fast track pharma & medical device ...

US FDA News: FDA approves new psoriasis drug

The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
Read more: FDA approves new psoriasis drug

Pharma Reviews: Time to Break in India

And that if we have to truly 'Make in India', we must ramp up our patent ... Our technological proficiency in pharmaceuticals came through the active ... yielding a world-class generic industry and affordable medications for our public.
Read more: Time to Break in India

Pharma Reviews: US pharma sector demands keeping India in patent violator list

America's pharma sector has asked US Trade Representative (USTR) to continue to keep India on its priority watch list (PWL) which includes countries ...
Read more: US pharma sector demands keeping India in patent violator list

US FDA News: HCG (Human Chorionic Gonadotropin) Freeze Dried Vials by Synergy Rx: Recall - Lack of Sterility Assurance

Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.
Read more: HCG (Human Chorionic Gonadotropin) Freeze Dried Vials by Synergy Rx: Recall - Lack of Sterility Assurance

Pharma Reviews: La Renon zooms to top 50 pharma cos list in India in less than a decade

Ahmedabad-based pharma company La Renon Healthcare that started its journey in 2008 with funds bootstrapped by founder Pankaj Singh who had ...
Read more: La Renon zooms to top 50 pharma cos list in India in less than a decade

Pharma Reviews: US pharma sector demands keeping India in patent violator list

Pharmaceutical Research and Manufacturers of America in a submission requested USTR to continue to keep India on the Priority Watch List in the ...
Read more: US pharma sector demands keeping India in patent violator list

Pharma Reviews: Pollux embarks on training mission

Mumbai, Feb 14 Taking a cue from the Drug Controller General of India's circular, skill development firm Pollux has drawn an initial training calendar ...
Read more: Pollux embarks on training mission

Pharma Reviews: Govt plans to establish pharma & medical technology zone at Bengaluru

India accounts for around 20 percent of the world's generic medicine supply chain, exporting to over 250 countries globally. Indian pharma industry ...
Read more: Govt plans to establish pharma & medical technology zone at Bengaluru

Pharma Reviews: Sun Pharma net falls by 4.7% in Q3 to Rs.1472 cr

Sun Pharmaceutical Industries, a leading Indian pharma companies with net sales of Rs.27,700 crore plus, has received setback during the third ...
Read more: Sun Pharma net falls by 4.7% in Q3 to Rs.1472 cr

Pharma Reviews: US pharma sector demands keeping India in patent violator list

WASHINGTON: America's pharma sector has asked US Trade Representative (USTR) to continue to keep India on its priority watch list (PWL) which ...
Read more: US pharma sector demands keeping India in patent violator list

Pharma Reviews: India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates ... The company's U.S. subsidiary Taro Pharmaceutical Industries Ltd last week ...
Read more: India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

Pharma Reviews: Commerce ministry to device action plan to reduce dependence on China for API imports

We have submitted our views about the pharma industry. ... domestic players to manufacture APIs in India at affordable rates rather than depending on ...
Read more: Commerce ministry to device action plan to reduce dependence on China for API imports

Pharma Reviews: Indian Pharmaceutical Alliance demands exclusion of India from USTR Priority Watch List

In a move aimed at removal of India from the USTR Priority Watch List, Indian Pharmaceutical Alliance (IPA) has filed its submission to the USTR for ...
Read more: Indian Pharmaceutical Alliance demands exclusion of India from USTR Priority Watch List

Pharma Reviews: Cipla global quality chief on data integrity violations: 'Bosses pushing juniors need to be whacked'

cipla, cipla integrity violation, indian pharma companies, medicine sector, USFDA, United India contributes around 30 per cent of the overall volume of ...
Read more: Cipla global quality chief on data integrity violations: 'Bosses pushing juniors need to be whacked'

Pharma Reviews: India demands greater access to China in pharma, IT sectors

While total trade between the two nations in 2016 stood at $71 billion in 2016, India witnessed a massive trade deficit of $46 billion with China, the ...
Read more: India demands greater access to China in pharma, IT sectors

Pharma Reviews: Govt delinks medical devices sector from pharmaceuticals

In a bid to foster 'Make in India' program, Centre has delinked the medical devices sector from pharmaceuticals sector. The medical devices vertical ...
Read more: Govt delinks medical devices sector from pharmaceuticals

Pharma Reviews: Pharma majors plan $2-billion investments to tap new business

Indian pharma companies' annual spending on research and development (R&D) might cross $2 billion by 2017-18. Companies such as Sun Pharma ...
Read more: Pharma majors plan $2-billion investments to tap new business

Pharma Reviews: Govt to amend norms to empower NPPA to fix prices of 350 drugs

BENGALURU: The government on Saturday said it will soon amend norms to empower National Pharmaceutical Pricing Authority (NPPA) to regulate ...
Read more: Govt to amend norms to empower NPPA to fix prices of 350 drugs

Pharma Reviews: New policy aims to make state a pharma hub

The Indian pharma industry is expected to grow at a rate of 15-20 per cent to reach a turnover of $50 billion by 2020. At present, 75 per cent of India's ...
Read more: New policy aims to make state a pharma hub

Pharma Reviews: Summit to draw future of pharma, medical devices

The Centre will organise a summit for the Indian pharmaceutical and medical devices industries and invite national and international entrepreneurs to ...
Read more: Summit to draw future of pharma, medical devices

Pharma Reviews: Bengaluru to get Pharma and Med Tech Zone

In this fiscal, the Indian pharma sector received Foreign Direct Investment close to $14 billion and has generated employment for over 2.5 million ...
Read more: Bengaluru to get Pharma and Med Tech Zone

Pharma Reviews: Govt to amend norms to empower NPPA to fix prices of 350 drugs

The Indian pharma industry has potential to reach USD 55 billion in the next couple of years from the current USD 33 billion, he added.
Read more: Govt to amend norms to empower NPPA to fix prices of 350 drugs

Pharma Reviews: Revisiting FTAs to protect local pharma, medical devices sector

BENGALURU: The government is reviewing and renegotiating existing free trade agreements (FTAs) India has signed with different countries to ...
Read more: Revisiting FTAs to protect local pharma, medical devices sector

Pharma Reviews: Govt to amend norms to empower NPPA to fix prices of 350 drugs

The Indian pharma industry has potential to reach USD 55 billion in the next couple of years from the current USD 33 billion, he added. (This article ...
Read more: Govt to amend norms to empower NPPA to fix prices of 350 drugs

Pharma Reviews: 'Revisiting FTAs to protect local pharma, med devices sector'

Bengaluru, Feb 11 (PTI) The government is reviewing and renegotiating existing free trade agreements (FTAs) India has signed with different ...
Read more: 'Revisiting FTAs to protect local pharma, med devices sector'

Pharma Reviews: Pharma and Med Tech Zone to be set up soon at Bengaluru: Ananthkumar

The India Pharma exhibition, being held as part of the event, will cover all the segments of the pharmaceutical industry starting from finished ...
Read more: Pharma and Med Tech Zone to be set up soon at Bengaluru: Ananthkumar

Pharma Reviews: India's Aurobindo plans second pharma plant in US as Trump calls for local production

His comments have worried some in India's roughly $15 billion pharmaceutical industry which supplies about 30% of the medicines sold in the United ...
Read more: India's Aurobindo plans second pharma plant in US as Trump calls for local production

Pharma Reviews: Indian pharma asks US to exclude India from list of IPR offenders

The Indian pharmaceutical industry has urged the Office of the United States Trade Representative (USTR), to remove India from its Priority Watch List ...
Read more: Indian pharma asks US to exclude India from list of IPR offenders

Pharma Reviews: Remove India from patent violator list: Indian pharma body to US

IPA represents twenty Indian pharmaceutical companies. The body collectively accounts for about 85 percent of private sector investment into ...
Read more: Remove India from patent violator list: Indian pharma body to US

Pharma Reviews: NSF International and IDMA Offer Pharmaceutical Quality Management Education in Bangalore

ANN ARBOR, Michigan, YORK, United Kingdom and BANGALORE, India, Feb. 10, 2017 /PRNewswire/ -- NSF International, a global public health ...
Read more: NSF International and IDMA Offer Pharmaceutical Quality Management Education in Bangalore

Pharma Reviews: Indian Pharma Companies May Pass On Costs Of A Border Tax To US Consumers, Says Lupin

Pharmaceutical companies are likely to pass on costs arising out of a border adjustment tax proposed by the Trump administration, to its customers in ...
Read more: Indian Pharma Companies May Pass On Costs Of A Border Tax To US Consumers, Says Lupin

US FDA News: FDA approves drug to treat Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.
Read more: FDA approves drug to treat Duchenne muscular dystrophy

Pharma Reviews: India pharma exports may see near double-digit growth

Indian pharma exports in the current financial year may see a near ... that of last year, a senior Ministry of Commerce and Industry official said here.
Read more: India pharma exports may see near double-digit growth

US FDA News: Federal judge approves consent decree with California dietary supplement distributor, Regeneca Worldwide

A California dietary supplement distributor has been ordered by a federal court to stop selling its products, which were found to contain unsafe ingredients including 1, 3-dimethylamylamine (DMAA).
Read more: Federal judge approves consent decree with California dietary supplement distributor, Regeneca Worldwide

US FDA News: Alaris Syringe Pump Module (Large Volume Pump), Model 8100 and AIL Sensor Kits by CareFusion: Class I Recall - Alarm Error

Faulty Air-In-Line sensor which may generate a false alarm, and cause the syringe pump to stop supplying the infusion to the patient. Interruption of infusion could lead to serious adverse health consequences or death.
Read more: Alaris Syringe Pump Module (Large Volume Pump), Model 8100 and AIL Sensor Kits by CareFusion: Class I Recall - Alarm Error

US FDA News: Ibuprofen Lysine Injection, 20 mg /2 mL (10 mg/mL) by Exela Pharma Sciences: Recall - Particulate Matter

Particulate matter has the potential to block blood vessels, provoke an immune reaction, and/or lead to microinfarcts which could be life threatening.
Read more: Ibuprofen Lysine Injection, 20 mg /2 mL (10 mg/mL) by Exela Pharma Sciences: Recall - Particulate Matter

US FDA News: Well Balance Xanthium & Siler Combo (Bi Yan Pian) Dietary Supplement by Kingsway Trading Inc.: Recall - Product Contains Banned Ephedra Alkaloids

Supplements containing ephedrine alkaloids pose a risk of serious adverse events, including heart attack, stroke, and death.
Read more: Well Balance Xanthium & Siler Combo (Bi Yan Pian) Dietary Supplement by Kingsway Trading Inc.: Recall - Product Contains Banned Ephedra Alkaloids

Pharma Reviews: India pharma exports may see near double-digit growth in FY17: Official

India pharma exports may see near double-digit growth in FY17: Official ... Hyderabad: Indian pharma exports in the current financial year may see a ... of last year, a senior Ministry of Commerce and Industry official said here today.
Read more: India pharma exports may see near double-digit growth in FY17: Official

Pharma Jobs: Officer/executive Quality Assurace with Pharma Company

Company: ELixir Web Solutions Private Limited
Qualification: B.Pharm, M.Pharm
Experience: 3 to 6
location: Pune
Ref: 20123836
Summary: Job Description We are glad to inform you that we have urgent opening with Pharma Company for the position of QA Officer/ Executive. Education : B Pharm/M Pharm Role and....
Read more: Officer/executive Quality Assurace with Pharma Company

Pharma Jobs: Executive-QA

Company: Piramal Enterprises
Qualification: B.Pharm
Experience: 3 to 7
Salary: 3.00 to 6.00
location: Indore
Ref: 20124181
Summary: Monitoring of product quality, in-process control and manufacturing environment. Ensure cGMP on shop floor along with documentation. Review all BMR, BPR for their correctness and ....
Read more: Executive-QA

Pharma Jobs: Executive-QC

Company: Piramal Enterprises
Qualification: B.Pharm
Experience: 3 to 7
Salary: 3.00 to 6.00
location: Indore
Ref: 20124182
Summary: Calibration of HPLC/GC, Dissolution, UV Spectrophotometer, FTIR etc. Volumetric solution preparation and standardization Working standard qualification and Reference standard....
Read more: Executive-QC

Pharma Jobs: Manager-QC

Company: Piramal Enterprises
Qualification: B.Pharm
Experience: 6 to 10
Salary: 7.00 to 15.00
location: Indore
Ref: 20124183
Summary: Good exposure on HPLC, GC, Dissolution apparatus and other QC instruments. Good knowledge on regulatory guidelines like ICH and FDA guidelines. Good knowledge on Handling of....
Read more: Manager-QC

Pharma Jobs: Executive-QC

Company: Piramal Enterprises
Qualification: B.Pharm
Experience: 3 to 7
Salary: 3.00 to 6.00
location: Indore
Ref: 20124184
Summary: - Sound knowledge on HPLC/GC, Dissolution, UV Spectrophotometer - Analysis of RM/ FG / Stability study samples - QC Documentation skills and sound knowledge of Computer -....
Read more: Executive-QC

Pharma Reviews: Making in India is alright, let's also 'Design and Develop', say pharma industry biggies

Hyderabad: From being a powerhouse of low-cost generics manufacturing, the Indian pharma industry must graduate to building competencies ...
Read more: Making in India is alright, let's also 'Design and Develop', say pharma industry biggies

Pharma Reviews: Pharma exports to grow 8-10% in FY17

The Indian pharma exports are on course to clocking an 8-10 per cent ... would be introduced to regulate foreign investment in pharma industry.
Read more: Pharma exports to grow 8-10% in FY17

Pharma Reviews: India pharma exports may see near double-digit growth in FY17: Official

HYDERABAD: Indian pharma exports in the current financial year may see a ... of last year, a senior Ministry of Commerce and Industry official said here today. ... Indian Pharma exports stood at $16.9 billion in the last financial year, ...
Read more: India pharma exports may see near double-digit growth in FY17: Official

Pharma Reviews: India pharma exports may see near double-digit growth in FY17

That is what is the anticipation, he Indian Pharma exports stood at USD ... year, a senior Ministry of Commerce and Industry official said here today.
Read more: India pharma exports may see near double-digit growth in FY17

Pharma Reviews: Pharma cos seek government support

Hyderabad: Indian pharma industry has been the powerhouse for global drugs market, bringing quality medicines at competitive prices compared to ...
Read more: Pharma cos seek government support

Pharma Reviews: Indian Pharmaceutical Alliance demands streamlining of approval of new drugs, biosimilars ...

Today Indian pharma's biggest bottleneck in overseas market is functioning of our drug regulatory system which is taken into account to determine ...
Read more: Indian Pharmaceutical Alliance demands streamlining of approval of new drugs, biosimilars ...

Pharma Reviews: 'Drug pricing control regime short-sighted'

Hyderabad: Up in arms against the central government's drug pricing control regime, the Indian pharma industry feels it is a short-sighted move that ...
Read more: 'Drug pricing control regime short-sighted'

Pharma Reviews: Reducing healthcare budget, pricing pressure squeezing pharma industry, say leaders

HYDERABAD: Indian pharma industry captains have reiterated their concerns over constant reduction in the healthcare budget of the Central ...
Read more: Reducing healthcare budget, pricing pressure squeezing pharma industry, say leaders

Pharma Reviews: Totally Trumped

The US is critical for Indian IT and pharmaceutical sectors. Of India's $108 billion IT export earnings, over 60 per cent come from the US. Similarly, 33 ...
Read more: Totally Trumped

Pharma Reviews: The Donald Trump trade: A primer for the Indian stock investor

Valuations of the Indian pharma sector have corrected by 45 percent over the last 18 months, mainly on the back of regulatory issues and concerns of ...
Read more: The Donald Trump trade: A primer for the Indian stock investor

Pharma Reviews: India-Venezuela ties: Petroleum university exchange programme in pipeline

India and Venezuela have stepped up cooperation in various sectors, including pharmaceutical industry and education and a new student exchange ...
Read more: India-Venezuela ties: Petroleum university exchange programme in pipeline

US FDA News: FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders

FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders
Read more: FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders

Pharma Reviews: Will not sell sick pharmaceutical firms to foreign companies: Government

India Pharmaceutical Industry, Indian Pharmaceutical Industry news, Pharmaceutical Industry news, India news, Stating that the government has not ...
Read more: Will not sell sick pharmaceutical firms to foreign companies: Government

Pharma Reviews: Govt will not sell sick pharma firms to foreign companies: Mansukh Mandaviya

Allaying the members' apprehensions, Mandaviya said: “There is no plan to sell Indian companies to foreign firms. ...the closing down of two pharma ...
Read more: Govt will not sell sick pharma firms to foreign companies: Mansukh Mandaviya

Pharma Reviews: Reactions of disappointments come out from pharma industry leaders and analysts on Union Budget.

Reactions from pharma industry leaders and analysts from various states show ... sector would destroy the Indian pharma industry and the drug trades.
Read more: Reactions of disappointments come out from pharma industry leaders and analysts on Union Budget.

Pharma Reviews: Will not sell sick pharma firms to foreign cos: Govt

Will not sell sick pharma firms to foreign cos: Govt ... closing down of Indian Drugs and Pharmaceuticals Ltd (IDPL) and Rajasthan Drugs and ... That apart, the domestic pharma industry is growing at over 12 per cent per annum and it ...
Read more: Will not sell sick pharma firms to foreign cos: Govt

US FDA News: Chlorhexidine Gluconate: Drug Safety Communication - Rare But Serious Allergic Reactions

Reactions can occur within minutes of exposure, and may include wheezing or difficulty breathing; swelling of the face; hives that can quickly progress to more serious symptoms; severe rash; or shock, a life-threatening condition.
Read more: Chlorhexidine Gluconate: Drug Safety Communication - Rare But Serious Allergic Reactions

Pharma Reviews: Budget impact: Drug firms may be forced to market generics, not brands

Organisation of Pharmaceutical Producers of India (OPPI), however, said rules are already in place to mandate generic prescription." A Medical ...
Read more: Budget impact: Drug firms may be forced to market generics, not brands

Pharma Reviews: Trump Presidency Impact | A Sickly Outlook

Indian drug makers currently export 15 to 55 per cent of locally made generic drugs to the US, which is the world's largest pharmaceutical market in ...
Read more: Trump Presidency Impact | A Sickly Outlook

Pharma Reviews: Pharma stocks pull BSE Healthcare up by 54%

In the Union Budget 2017-18, Union Finance Minister Arun Jaitley had announced a slew of measures for the Indian Pharma sector, the major ...
Read more: Pharma stocks pull BSE Healthcare up by 54%

Pharma Reviews: Budget 2017 proposals receive mixed reaction from pharma sector

MUMBAI: The pharma sector representatives said the Union Budget has ... addressed imminent challenges directly affecting the sector, KPMG India ...
Read more: Budget 2017 proposals receive mixed reaction from pharma sector

Pharma Reviews: Sun Pharma and Aurobindo Pharma pull BSE Healthcare up by 54 points

Sun Pharmaceuticals Industries and Aurobindo Pharma have pulled the BSE Healthcare index by 54% ... The Indian markets opened flat on Thursday.
Read more: Sun Pharma and Aurobindo Pharma pull BSE Healthcare up by 54 points

Pharma Reviews: Govt abolishes FIPB

FIPB handled those projects that need government approval in sectors like ... The Congress leader contended that the Indian pharma industry was ...
Read more: Govt abolishes FIPB

Pharma Reviews: Pharma sector finds budget 'safe' but not path breaking

The Indian pharmaceutical industry has for the past couple of years complained that it tends to get more or less ignored in the budget, and though ...
Read more: Pharma sector finds budget 'safe' but not path breaking

Pharma Reviews: Budget receives mixed reaction from pharma sector

The pharma sector representatives said the Union Budget has failed to ... addressed imminent challenges directly affecting the sector, KPMG India ...
Read more: Budget receives mixed reaction from pharma sector

Pharma Reviews: Union Budget 2017-18: Do big drug cos stand to lose on proposed rejig of pharma rules?

"Prima facie - the announcement is negative," said DG Shah, Secretary General of Indian Pharmaceutical Alliance, the industry body that represents ...
Read more: Union Budget 2017-18: Do big drug cos stand to lose on proposed rejig of pharma rules?

Pharma Reviews: Pharma sector unimpressed with the Union Budget

“I would have expected some pro-pharma industry measures in terms of incentives to research and some tax relief. Quality healthcare for India would ...
Read more: Pharma sector unimpressed with the Union Budget

Pharma Reviews: Pharma industry reacts positively to Budget 2017-18

Welcoming the budget, DG Shah, Secretary General of Indian Pharmaceutical Alliance said the increase in social and infrastructure spending in the ...
Read more: Pharma industry reacts positively to Budget 2017-18

Pharma Reviews: Dismantling FIPB might improve ease of doing business

Now, another mechanism would deal with it”, said D G Shah, Secretary General of Indian Pharmaceutical Alliance (IPA) a lobby group of leading ...
Read more: Dismantling FIPB might improve ease of doing business

Pharma Reviews: Trump's call to pharma firms to move back to US could hit Indian exporters

Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald Trump told drug ...
Read more: Trump's call to pharma firms to move back to US could hit Indian exporters

Pharma Reviews: IDMA, UK-based NSF to jointly launch course on quality management for QA professionals in India

The Indian Drug Manufacturers Association (IDMA) and the UK-based agency NSF International have collaborated to jointly start Advanced ...
Read more: IDMA, UK-based NSF to jointly launch course on quality management for QA professionals in India